Global Glycomics Market Scope And Analysis

  • Report Code : TIPRE00003794
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 274
Buy Now

Glycomics Market Scope, Analysis, and Trends by 2028

Buy Now


Glycomics Market Report Scope

Report Attribute Details
Market size in 2021 US$ 1.34 Billion
Market Size by 2028 US$ 3.22 Billion
Global CAGR (2021 - 2028) 13.4%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Product
  • Instruments
  • Enzymes
  • Reagents
  • Kits
By Application
  • Drug Discovery and Development
  • Diagnostics
  • Immunology
  • Cancer
By End User
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Contract Research Organizations
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Merck KGaA
  • Agilent Technologies Inc
  • New England Biolabs
  • Thermo Fisher Scientific Inc
  • Waters Corporation
  • Asparia Glycomics
  • Bruker Corporation
  • Takara Bio Inc
  • S BIO
  • End User-Based Insights

    Based on end user, the global glycomics market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, and contract research organizations. The pharmaceutical and biotechnology companies’ segment would hold the largest market share in 2021, and the same segment is expected to grow at the highest CAGR during the forecast period.

    The glycomics market players adopt organic strategies such as product launch and expansion to expand their footprint and product portfolio worldwide and meet the growing demand. Some major players contributing to the glycomics market are Merck KGaA; Agilent Technologies, Inc.; New England Biolabs; Thermo Fisher Scientific Inc.; Waters Corporation; Asparia Glycomics; Bruker Corporation; Takara Bio Inc.; S-BIO; and Shimadzu Corporation, among others.